CD4+ helper T cells and cytotoxic CD8+ T cells play an important role in tumor prevention by targeting antigenic tumor cells, and CD8+ T cells are associated with better clinical outcomes and immunotherapeutic responses in many cancers. This evidence concerns the gene CD4 and neoplasm.